Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Cognitive Performance, clinical characteristics and glycemic control data of the study sample. MHAS 2012 Cognitive Performance | Total | Low≤44.0 | Intermediate44.1 to 59.52 | High≥59.53 | P | Mean (SD)/nn/SD (%) | n = 216 | n = 76 | n = 68 | n = 72 |: Vitamin D | 21.13 (6.83) | 20.85 (7.40) | 20.94 (6.40) | 21.60 (6.67) | .779

Source: Results table. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Type 2 DM participants were classified in 3 groups according to their glycated hemoglobin levels (HbA1c): < 7% (intensive control), 7 to 7.9% (standard control) or ≥ 8% (poor control), and cognitive performance: low (CCCE ≤44 points), intermediate (44.1 to 59.52 points), or high (≥59.53 points).

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Effect of poor glycemic control in cognitive performance in the elderly with type 2 diabetes mellitus: The Mexican Health and Aging Study

Study design awaiting verification · BMC Geriatrics · 2020

Original publication title

Effect of poor glycemic control in cognitive performance in the elderly with type 2 diabetes mellitus: The Mexican Health and Aging Study

Alberto J. Mimenza-Alvarado; Gilberto A. Jiménez-Castillo; Sara G. Yeverino-Castro; Abel J. Barragán-Berlanga; Mario U. Pérez-Zepeda; J. Alberto Ávila-Funes; Sara G. Aguilar-Navarro

© The Author(s) 2020

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Glycemic control with a HbA1c ≥ 8% was associated with worse cognitive performance.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Cognitive impairment is twice more frequent in elderly with type 2 diabetes mellitus (DM). This study was conducted to determine the association between glycemic control and cognitive performance among community-dwelling elderly persons in Mexico.

Source: Background

Abstract: What methods does the paper describe?

Cross-sectional study conducted in individuals aged 60 years or elderly participating in the 2012 Mexican Health and Aging Study. Type 2 DM participants were classified in 3 groups according to their glycated hemoglobin levels (HbA1c): < 7% (intensive control), 7 to 7.9% (standard control) or ≥ 8% (poor control), and cognitive performance: low (CCCE ≤44 points), intermediate (44.1 to 59.52 points), or high (≥59.53 points). Multinomial logistic regression models were constructed to determine this association.

Source: Methods

Abstract: Results

Two hundred sixteen community-dwelling adults aged 60 and older with type 2 diabetes were selected. Subjects in the low cognitive performance group were older (69.7 ± 6.6 vs 65.86 ± 5.18 years, p < .001) and had a lower educational level (2.5 ± 2.6 vs 7.44 ± 4.15 years, p < .000) when compared to the high cognitive performance participants. HbA1c ≥ 8% was associated with having low (Odds Ratio (OR) 3.17, 95% CI 1.17 to 8.60, p = .024), and intermediate (OR 3.23, 95% CI 1.27 to 8.20, p = .014) cognitive performance; this trend was not found for HbA1c 7.0 to 7.9% group.

The multinomial regression analysis showed that the presence of HbA1c ≥ 8% (poor glycemic control) was associated with low (OR 3.17, 95% CI = 1.17 to 8.60, p = .024), and intermediate (OR 3.23, 95% CI = 1.27 to 8.20, p = .014) cognitive performance. After adjusting for confounding variables.

Source: Results Source: Results

Abstract: Conclusions

Glycemic control with a HbA1c ≥ 8% was associated with worse cognitive performance.

Source: Conclusions
Authors’ abstract

Background

Cognitive impairment is twice more frequent in elderly with type 2 diabetes mellitus (DM). This study was conducted to determine the association between glycemic control and cognitive performance among community-dwelling elderly persons in Mexico.

Methods

Cross-sectional study conducted in individuals aged 60 years or elderly participating in the 2012 Mexican Health and Aging Study. Type 2 DM participants were classified in 3 groups according to their glycated hemoglobin levels (HbA1c): < 7% (intensive control), 7 to 7.9% (standard control) or ≥ 8% (poor control), and cognitive performance: low (CCCE ≤44 points), intermediate (44.1 to 59.52 points), or high (≥59.53 points). Multinomial logistic regression models were constructed to determine this association.

Results

Two hundred sixteen community-dwelling adults aged 60 and older with type 2 diabetes were selected. Subjects in the low cognitive performance group were older (69.7 ± 6.6 vs 65.86 ± 5.18 years, p < .001) and had a lower educational level (2.5 ± 2.6 vs 7.44 ± 4.15 years, p < .000) when compared to the high cognitive performance participants. HbA1c ≥ 8% was associated with having low (Odds Ratio (OR) 3.17, 95% CI 1.17 to 8.60, p = .024), and intermediate (OR 3.23, 95% CI 1.27 to 8.20, p = .014) cognitive performance; this trend was not found for HbA1c 7.0 to 7.9% group.

The multinomial regression analysis showed that the presence of HbA1c ≥ 8% (poor glycemic control) was associated with low (OR 3.17, 95% CI = 1.17 to 8.60, p = .024), and intermediate (OR 3.23, 95% CI = 1.27 to 8.20, p = .014) cognitive performance. After adjusting for confounding variables.

Conclusions

Glycemic control with a HbA1c ≥ 8% was associated with worse cognitive performance.

Publication and source details

Original title: Effect of poor glycemic control in cognitive performance in the elderly with type 2 diabetes mellitus: The Mexican Health and Aging Study

Alberto J. Mimenza-Alvarado; Gilberto A. Jiménez-Castillo; Sara G. Yeverino-Castro; Abel J. Barragán-Berlanga; Mario U. Pérez-Zepeda; J. Alberto Ávila-Funes; Sara G. Aguilar-Navarro

BMC Geriatrics · 2020

© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Consejo Nacional de Ciencia y tecnologia (CONACYT) (FOSISS 2017-1 290406 2017. GER-2416-18-20-1)Secretaría de Ciencia y Técnica, Universidad de Buenos Aires (AR)(FOSISS 2017-1 290406 2017

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T14:22:13.695320+00:00

DOI: 10.1186/s12877-020-01827-x · PMC7585218